Hong Kong-based AI developer creates COVID-19 survival calculator
The online tool provides a COVID-19 patient’s risk score, expected time to death and survival probability curve based on 15 health variables.
Related Articles
AI-enabled drug discovery company Xaira launches with $1B
Xaira’s CEO, Dr. Marc Tessier-Lavigne, resigned as president of Stanford University last August due to controversy over inaccuracies discovered in his lab’s scientific papers.
GE HealthCare partners with Elekta to enhance radiation therapy
Elekta’s radiation therapy offerings will now utilize GE HealthCare’s recently acquired MIM software.
ABOUT Healthcare acquires AI analytics company Edgility
The SaaS company looks to harness Edgility’s AI capabilities to expand its patient capacity offerings and augment its patient flow model.
Increasing patient confidence in the doctor’s office through positive
PatientPoint Chief Product and Strategy Officer Andrew Schultz chats about building a communication hub between patients and providers that fosters a more connected health ecosystem…
New technology must bridge fractured healthcare systems
Dr. Monika Sonu, cofounder and director of new product development at Healthinnovation Toolbox and 2024 Changemaker, says she believes all digital health tools should address…
ShiftMed acquires CareerStaff Unlimited to bolster nursing platform
As part of the agreement, ShiftMed will provide services to 1,400 Genesis HealthCare locations.
Value-based care strategy company Lumeris secures $100M
The health technology company will use the funds to support the growth of its provider partnerships.
How technology can bring nurses closer to patients
MaryAnn Connor, senior director of nursing informatics at Memorial Sloan Kettering Cancer Center, discusses how nurses must understand the whole patient and their needs, and…
NIH develops AI tool to better pair cancer patients with drugs
The proof-of-concept study published in Nature Cancer highlights how researchers are using tumor cells to predict whether patients will respond to specific drugs.
NIH develops AI tool to better pair cancer patients with drugs
The proof-of-concept study published in Nature Cancer highlights how researchers are using tumor cells to predict whether patients will respond to specific drugs.